MedPath
FDA Approval

Terbinafine Hydrochloride

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
December 15, 2017
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Terbinafine(250 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Aphena Pharma Solutions - Tennessee, LLC

Aphena Pharma Solutions - Tennessee, LLC

128385585

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Terbinafine Hydrochloride

Product Details

NDC Product Code
43353-893
Application Number
ANDA077714
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
December 15, 2017
Silicon DioxideInactive
Code: ETJ7Z6XBU4Class: IACT
Code: 012C11ZU6GClass: ACTIMQuantity: 250 mg in 1 1
Microcrystalline CelluloseInactive
Code: OP1R32D61UClass: IACT
Hypromellose, UnspecifiedInactive
Code: 3NXW29V3WOClass: IACT
Sodium Starch Glycolate Type A PotatoInactive
Code: 5856J3G2A2Class: IACT
Magnesium StearateInactive
Code: 70097M6I30Class: IACT
© Copyright 2025. All Rights Reserved by MedPath